News|Articles|October 19, 2023

Peptide analytical method development (Oct 2023)

Analytical Method Development for Synthetic Peptide Purity and Impurities Content by UHPLC - Illustrated Case Study

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

BySCIEX

November 10th 2025

Improving end-to-end metabolite identification by LC-MS/MS

BySCIEX

November 10th 2025

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

BySCIEX

November 10th 2025

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

BySCIEX

November 10th 2025

Targeted high resolution metabolite screening workflows

BySCIEX

November 10th 2025

Peptide analytical method development (Oct 2023)

Newsletter

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

Improving end-to-end metabolite identification by LC-MS/MS

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

Targeted high resolution metabolite screening workflows

Trending on Pharmaceutical Technology

How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

Implications on SMA Care of High-Dose Nusinersen